Literature DB >> 35857132

Efficacy of multi-strain probiotic along with dietary and lifestyle modifications on polycystic ovary syndrome: a randomised, double-blind placebo-controlled study.

Ishwarpreet Kaur1, Vanita Suri2, Naresh Sachdeva3, Satya Vati Rana4, Bikas Medhi5, Nancy Sahni6, Jayesh Ahire7, Amarjeet Singh8.   

Abstract

PURPOSE: Effect of multi-strain probiotic along with dietary and lifestyle modifications in the management of polycystic ovary syndrome (PCOS) has rarely been reported. We thus aimed to investigate the effect of multi-strain probiotic (Lactobacillus acidophilus UBLA-34, L. rhamnosus UBLR-58, L. reuteri UBLRu-87 (each of 2 billion colony forming units (CFU)); L. plantarum UBLP-40, L. casei UBLC-42, L. fermentum UBLF-31, Bifidobacterium bifidum UBBB-55 (each of 1 billion CFU) and fructo-oligosaccharides (100 mg)) and dietary and lifestyle modifications on restoration of menstrual regularity, weight reduction, metabolic and hormonal profile in women with PCOS.
METHODS: A 104 participants (age 18-40 years) were randomly allocated to receive probiotic or placebo capsules for 6 months. Baseline and end line assessment were performed for menstrual cycle regularity, ultrasonography scan for ovaries, total testosterone, dehydroepiandrosterone (DHEAS), insulin, luteinizing hormone/follicle stimulating hormone (LH/FSH) ratio, fasting blood sugar (FBS), homeostatic model assessment-insulin resistance (HOMA-IR), weight reduction, waist-/hip circumference (WC, HC), waist to hip ratio (WHR), and body mass index (BMI). Plasma lipopolysaccharide and effect of intervention on quality of life was investigated. Diet and exercise were controlled during the trial.
RESULTS: Probiotic supplement along with dietary and lifestyle modifications significantly regularised menstrual cycle (p 0.023), improved levels of total testosterone (p 0.043), WC (p 0.030), WHR (p 0.027) and menstrual domain of quality of life (p 0.034) as compared to placebo. No adverse events related to study were reported.
CONCLUSION: Multi-strain probiotic along with dietary and lifestyle modifications were effective in the management of PCOS. TRIAL REGISTRATION: CTRI: CTRI/2016/07/007086, dated 13 July 2016.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Lipopolysaccharide; Menstrual cycle; PCOS; Probiotic; Testosterone

Year:  2022        PMID: 35857132     DOI: 10.1007/s00394-022-02959-z

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   4.865


  27 in total

1.  Worldwide Dissatisfaction With the Diagnostic Process and Initial Treatment of PCOS.

Authors:  Melanie Cree-Green
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

2.  Lifestyle Modifications in PCOS.

Authors:  Jasmine M Aly; Alan H Decherney
Journal:  Clin Obstet Gynecol       Date:  2021-03-01       Impact factor: 2.190

3.  Pharmacologic Treatments for PCOS Patients.

Authors:  Samantha Kodama; Saioa Torrealday
Journal:  Clin Obstet Gynecol       Date:  2021-03-01       Impact factor: 2.190

4.  Role of metformin in the management of polycystic ovary syndrome.

Authors:  Hany Lashen
Journal:  Ther Adv Endocrinol Metab       Date:  2010-06       Impact factor: 3.565

Review 5.  Targets to treat androgen excess in polycystic ovary syndrome.

Authors:  Manuel Luque-Ramírez; Héctor Francisco Escobar-Morreale
Journal:  Expert Opin Ther Targets       Date:  2015-09-07       Impact factor: 6.902

6.  Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience.

Authors:  Yong-Su Jang; Eun Sil Lee; Yang-Ki Kim
Journal:  Obstet Gynecol Sci       Date:  2021-04-01

Review 7.  Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

Authors:  H Teede; A Deeks; L Moran
Journal:  BMC Med       Date:  2010-06-30       Impact factor: 8.775

8.  Natural approaches in metabolic syndrome management.

Authors:  Angelo Maria Patti; Khalid Al-Rasadi; Rosaria Vincenza Giglio; Dragana Nikolic; Carlo Mannina; Giuseppa Castellino; Roberta Chianetta; Maciej Banach; Arrigo F G Cicero; Giuseppe Lippi; Giuseppe Montalto; Manfredi Rizzo; Peter P Toth
Journal:  Arch Med Sci       Date:  2017-07-19       Impact factor: 3.318

9.  Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Somayeh Abdolahian; Fahimeh Ramezani Tehrani; Mina Amiri; Delaram Ghodsi; Razieh Bidhendi Yarandi; Mahdi Jafari; Hamid Alavi Majd; Fatemeh Nahidi
Journal:  BMC Endocr Disord       Date:  2020-05-19       Impact factor: 2.763

Review 10.  Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.

Authors:  Mohammad Ashraf Ganie; Vishnu Vasudevan; Imtiyaz Ahmad Wani; Mohammad Salem Baba; Tasleem Arif; Aafia Rashid
Journal:  Indian J Med Res       Date:  2019-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.